Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Med Gas Res ; 10(4): 185-188, 2020.
Article in English | MEDLINE | ID: mdl-33380586

ABSTRACT

Diabetic nephropathy is one of the most important comorbidities in the diabetic population. In China, more and more young patients are showing an increasing prevalence of diabetes. As a gas molecule, hydrogen sulfide (H2 S) has some unique chemical and physiological functions. In recent years, it has been studied in various fields. These effects are manifested in the induction of renal vasodilation and anti-renal vascular fibrosis. The ball clearing function is improved. Therefore, increasing prospective studies have focused on how H2 S protects diabetic nephropathy and how to obtain H2 S by modern means to treat diabetic nephropathy.


Subject(s)
Hydrogen Sulfide/pharmacology , Diabetic Nephropathies/drug therapy , Humans , Hydrogen Sulfide/therapeutic use
2.
Med Gas Res ; 10(1): 50-53, 2020.
Article in English | MEDLINE | ID: mdl-32189670

ABSTRACT

Glioma is one of the most frequent primary brain tumors. Currently, the most common therapeutic strategy for patients with glioma is surgical resection combined with radiotherapy or/and adjuvant chemotherapy. However, due to the metastatic and invasive nature of glioma cells, the recurrence rate is high, resulting in poor prognosis. In recent years, gas therapy has become an emerging treatment. Studies have shown that the proliferation, metastasis and invasiveness of glioma cells exposed to anesthetic gases are obviously inhibited. Therefore, anesthetic gas may play a special therapeutic role in gliomas. In this review, we aim to collect existing research and summarize the rules of using anesthetic gases on glioma, providing potential strategies for further clinical treatment.


Subject(s)
Anesthetics, Inhalation/pharmacology , Gases/pharmacology , Glioma , Glioma/pathology , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...